Journal of Psychoactive Drugs

Papers
(The median citation count of Journal of Psychoactive Drugs is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–202062
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health41
Prevalence and Correlates of GHB Use among Adults in the United States33
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey27
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool26
Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing23
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives23
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies21
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan20
Religion, Psychedelics, Risky Behavior, and Violence18
Harm Reduction Strategies among University Students Who Use Alcohol and Cannabis, and Related Psychological Variables: A Systematic Review17
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders15
The Epidemiology of Psychedelic Use Among United States Military Veterans15
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers14
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence14
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine13
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency13
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students12
“It’s so Natural It Goes Hand in Hand”: A Qualitative Study of Maternal Perceptions of Cannabis Use during Pregnancy11
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study11
Naturalistic Psychedelic Use: A World Apart from Clinical Care11
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use11
Religious Social Integration, Psychedelics, and Psychological Distress11
From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?10
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context10
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders10
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis10
Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms10
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment10
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge9
Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment9
Psychedelic Use and Behavioral Addictions9
Cortisol/DHEA-S Ratio Normalization by Buprenorphine: Associations with Stress, Coping, and Social Support in Youth with Opioid Use Disorder9
Psychedelic Microdosing among Young Adults from Southern California9
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand9
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials9
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic9
Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania9
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties9
Minor Cannabinoid Use Among Medical Cannabis Patients9
Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids8
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)8
The Protective Role of Savoring on Coping Motives for Cannabis Use and Consequences8
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies8
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use8
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes7
Examining Volunteer Bias in Psychedelic Research7
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review7
Kratom Retail Availability in Fort Worth, Texas7
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study7
Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay7
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics7
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital7
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study7
Acculturation Style Is Associated with Stress and Tobacco Use among East African Immigrants7
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?7
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products7
The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot Study6
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals6
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?6
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy6
MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials6
Death Anxiety Among Users and Non-Users of Psychedelics6
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences6
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking6
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine5
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey5
Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders5
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets5
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico5
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts5
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics5
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review5
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption5
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium5
How Personal Attitudes About Legalizing Cannabis and Corresponding State Laws Affect the Stigma of Cannabis Use5
Prevalence of Substance Use Among Asian Sexual Minority Individuals in the United States, 2015-20205
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia5
The Association of Substance Use Disorder (SUD) Type and Other Factors in SUD Recognition Among U.S. Adults5
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review5
The Complexity of Impulsivity Dimensions among Abstinent Individuals with Substance Use Disorders4
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses4
Weeding Out the Stigma: Older Veterans in Illinois Share Their Experiences Using Medical Cannabis4
Substance use Attitudes, Beliefs, Experience, and Knowledge Among Nursing and Nursing Assistant Students4
The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample4
Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay4
Chemsex and Harm Reduction Practices Among Men Who Have Sex with Men in Malaysia: Findings from a Qualitative Study4
In Memoriam: Roland R. Griffiths (July 19, 1946–October 16, 2023)4
Rapid Effects of MDMA Administration on Self-Reported Personality Traits and Affect State: A Randomized, Placebo-Controlled Trial in Healthy Adults4
Health-Promoting Behaviors in Male Patients with Opioid Use Disorder: An Exploratory Study4
Caregivers’ Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study4
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States4
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts4
Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America4
Pain Intensity and Hazardous Cannabis Use: The Moderating Role of Pain-related Anxiety4
O-Know Opioid Knowledge Test: Development and Psychometric Testing in a Community Setting4
Examining Predictors of Nicotine Dependence in Korean Adolescents : Comparing Ever Quitters and Never Quitters4
Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation4
The Role of Savoring in Young Adult Cannabis Use and Associated Consequences: A Replication Study4
Driving Under the Influence of Alcohol, Cannabis, and Delta-8 THC: Perceived Likelihood, Risk Perceptions, and Behaviors4
Depression and Substance Use Among Brazilian University Students During the COVID-19 Pandemic3
Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice3
The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review3
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically3
Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing3
What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes3
Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders3
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use3
Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants3
Drug use Risks in Portuguese Rural vs Urban Environments: Harm Reduction Challenges in a Progressive Drug Policy Setting3
Predictors of Psychedelic Experience: A Thematic Analysis3
Efficacy of Extended-Release Injectable Naltrexone on Alcohol Use Disorder Treatment: A Systematic Review3
The Healthcare Profession as a Determinant of Depression, Suicidal Ideation, and Drug Use in Spain During the COVID-19 Pandemic Crisis3
Exploring Polysubstance Use with a Data Mining Approach in Individuals with and without Mental Health Conditions3
Kratom Consumption – The Tales of Three Patients3
Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration3
Ethical Issues in Treating Substance Use Disorders: Counselor Perspectives3
Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study3
Prevalence and Predictors of Psychoactive Drug Use among Chinese Men Who Have Sex with Men: A Longitudinal and Mediation Study3
Lived Experiences of Nonmedical Use of Tramadol Among Urban Slum-Dwelling Youth in Ghana: A Qualitative Study3
Policy and Practice Changes Associated with a Tobacco-Free Initiative in Residential Substance Use Disorder Treatment3
Cannabis and Cocaine, Heroin, or Methamphetamine Use and Factors Associated with Multiple Drug Use and Drug Treatment in a Nationally Representative Sample3
Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience3
Safety of Alprazolam Use in Pregnancy in Western Australia: A Retrospective Cohort Study Using Linked Health Data3
Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept2
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?2
Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users2
Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Factor Analysis Replication, Internal Reliability, and Construct Validity2
A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube2
Psychedelic Use and Intimacy: A Systematic Review of Experimental and Naturalistic Research2
Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts2
Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use2
Exploring Cultural Competence, Inclusivity, and Diversity in Ketamine Assisted Psychotherapy: A Phenomenological Study2
Kratom: A Bibliometric Analysis of Scientific Publications2
Fear of COVID-19 Diagnosis and Cannabis Use Patterns Among Adults with Chronic Health Conditions: Results from COVID-19 Cannabis Health Study2
Psychometric Validity of the Minnesota Tobacco Withdrawal Scale in Smokers Attempting to Quit: Longitudinal Invariance across Smokers and Abstainers2
A Systematized Review of Drug-checking and Related Considerations for Implementation as A Harm Reduction Intervention2
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study2
Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes2
Smoking Outcome Expectancies in Chinese Young Adults2
Risk and Protective Factors Associated with Drug Use in Healthcare Professionals: A Systematic Review2
Magic of the Mushrooms: Effects of Psilocybin Decriminalization2
Effects of Positive versus Negative Framing on Stigma toward Individuals Recovering from Methamphetamine Use Disorder during Randomized Brief Video Exposure2
Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users2
Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally2
Spiritual Well-Being Among Users and Non-Users of Psychedelics: A Cross-Sectional Study2
A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder2
Predictors of Five-year Readmission to an Inpatient Service among Patients with Opioid Use Disorders2
Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City2
The Effects of Neighborhood Disorder on Polydrug Use: Examining Depressive Symptoms and Deviant Peer Association as Mediating Mechanisms2
Prevalence and Patterns of Cannabis Product Adulteration: An Analysis of WEDINOS Data2
Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States2
Indigenous Voices in Psychedelic Therapy: Experiential Learnings from a Community-Based Group Psychedelic Therapy Program2
Sexual Assault Victimization in Premature Female Mortalities: Evidence from the National Longitudinal Study of Adolescent to Adult Health2
A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy2
Resilience Through Harm Reduction? Protective Behavioral Strategies as a Factor of Resilience Among Polish Young Adults Using Various Psychoactive Substances2
Factors Associated with Psychosis in 2098 Methamphetamine Users Admitted to 104 Outpatient Counseling Centers in 80 Cities in Turkey2
Therapeutic Use and Other Reasons to Consume Cannabidiol: Insight from the French and Italian Contexts2
Combat Veterans’ Experiences of Moral Injury, Cannabis Use Disorder and the Process of Meaning-Making: A Mixed Methods Study2
Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample2
Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences2
The Index of Cannabis Equivalence (ICE): A User-Centered Approach to Standardization of Cannabis Dose–Response2
0.063601970672607